These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 12829979)

  • 1. Kinetics of the immune response during HBV and HCV infection.
    Bertoletti A; Ferrari C
    Hepatology; 2003 Jul; 38(1):4-13. PubMed ID: 12829979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunology of hepatitis B and hepatitis C virus infections.
    Boonstra A; Woltman AM; Janssen HL
    Best Pract Res Clin Gastroenterol; 2008; 22(6):1049-61. PubMed ID: 19187866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of viral and host factors in HCV persistence: which lesson for therapeutic and preventive strategies?
    Missale G; Cariani E; Ferrari C
    Dig Liver Dis; 2004 Nov; 36(11):703-11. PubMed ID: 15570998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology of hepatitis B virus and hepatitis C virus infection.
    Rehermann B; Nascimbeni M
    Nat Rev Immunol; 2005 Mar; 5(3):215-29. PubMed ID: 15738952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of the virus specific T-cell response in acute and chronic HBV and HCV infection].
    Panther E; Spangenberg HC; Neumann-Haefelin C; Rösler K; Blum HE; von Weizsäcker F; Thimme R
    Z Gastroenterol; 2004 Jan; 42(1):39-46. PubMed ID: 14997402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunopathogenesis of viral hepatitis.
    Mateescu RB; Rimbaş M; Voiosu R
    Rom J Intern Med; 2004; 42(1):59-67. PubMed ID: 15529595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment predictors of a sustained virologic response in hepatitis B and C.
    Kau A; Vermehren J; Sarrazin C
    J Hepatol; 2008 Oct; 49(4):634-51. PubMed ID: 18715665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.
    Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Bartolomé J; Pardo M; Carreño V
    J Med Virol; 2007 Mar; 79(3):236-41. PubMed ID: 17245725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
    Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
    Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host genetics in immune-mediated hepatitis C virus clearance.
    Schmidt J; Thimme R; Neumann-Haefelin C
    Biomark Med; 2011 Apr; 5(2):155-69. PubMed ID: 21473719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A target on the move: innate and adaptive immune escape strategies of hepatitis C virus.
    Thimme R; Lohmann V; Weber F
    Antiviral Res; 2006 Mar; 69(3):129-41. PubMed ID: 16413618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneously acute hepatitis B virus and C virus coinfection and subsequent chronic hepatitis C.
    Chen SW; Lee TS; Hu CC; Chang LC; Chien RN
    Scand J Infect Dis; 2007; 39(4):351-4. PubMed ID: 17454901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B and C virus infections and anti-tumor necrosis factor-alpha therapy: guidelines for clinical approach.
    Nathan DM; Angus PW; Gibson PR
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1366-71. PubMed ID: 16911678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBV and HCV infection in Japanese dental care workers.
    Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M
    Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent detection of hepatitis B virus DNA in hepatocellular carcinoma of patients with sustained virologic response for hepatitis C virus.
    Tamori A; Hayashi T; Shinzaki M; Kobayashi S; Iwai S; Enomoto M; Morikawa H; Sakaguchi H; Shiomi S; Takemura S; Kubo S; Kawada N
    J Med Virol; 2009 Jun; 81(6):1009-14. PubMed ID: 19382258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a heterologous, multigenotype vaccine against hepatitis C virus infection.
    Encke J; Radunz W; Eisenbach C; Geib J; Gehrke S; Pfaff E; Stremmel W
    Eur J Clin Invest; 2007 May; 37(5):396-406. PubMed ID: 17461986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of hepatitis B and C virus infections among Lao blood donors.
    Jutavijittum P; Yousukh A; Samountry B; Samountry K; Ounavong A; Thammavong T; Keokhamphue J; Toriyama K
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):674-9. PubMed ID: 17883005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.